HK1047748B - 在第六環上取代的二環咪唑並-3-基-胺的衍生物 - Google Patents

在第六環上取代的二環咪唑並-3-基-胺的衍生物

Info

Publication number
HK1047748B
HK1047748B HK02109383.4A HK02109383A HK1047748B HK 1047748 B HK1047748 B HK 1047748B HK 02109383 A HK02109383 A HK 02109383A HK 1047748 B HK1047748 B HK 1047748B
Authority
HK
Hong Kong
Prior art keywords
substituted
ring
amine derivatives
bicyclic imidazo
imidazo
Prior art date
Application number
HK02109383.4A
Other languages
English (en)
Other versions
HK1047748A1 (en
Inventor
Gerlach Matthias
Maul Corinna
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19948434A external-priority patent/DE19948434A1/de
Priority claimed from DE1999148437 external-priority patent/DE19948437A1/de
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of HK1047748A1 publication Critical patent/HK1047748A1/xx
Publication of HK1047748B publication Critical patent/HK1047748B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK02109383.4A 1999-10-08 2002-12-28 在第六環上取代的二環咪唑並-3-基-胺的衍生物 HK1047748B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19948434A DE19948434A1 (de) 1999-10-08 1999-10-08 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
DE1999148437 DE19948437A1 (de) 1999-10-08 1999-10-08 Am Sechsring substituierte, bicyclische Imidazo-3-aminderivate
PCT/EP2000/009095 WO2001027110A2 (de) 1999-10-08 2000-09-18 Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate

Publications (2)

Publication Number Publication Date
HK1047748A1 HK1047748A1 (en) 2003-03-07
HK1047748B true HK1047748B (zh) 2004-10-21

Family

ID=26055217

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02109383.4A HK1047748B (zh) 1999-10-08 2002-12-28 在第六環上取代的二環咪唑並-3-基-胺的衍生物

Country Status (27)

Country Link
US (1) US6849642B2 (zh)
EP (1) EP1218380B1 (zh)
JP (1) JP2003517466A (zh)
KR (1) KR20020038804A (zh)
CN (1) CN1222525C (zh)
AR (1) AR025961A1 (zh)
AT (1) ATE256684T1 (zh)
AU (1) AU780823B2 (zh)
BR (1) BR0014826A (zh)
CA (1) CA2386813C (zh)
CO (1) CO5210870A1 (zh)
CZ (1) CZ300315B6 (zh)
DE (1) DE50004817D1 (zh)
DK (1) DK1218380T3 (zh)
ES (1) ES2213044T3 (zh)
HK (1) HK1047748B (zh)
HU (1) HUP0203739A3 (zh)
IL (2) IL148998A0 (zh)
MX (1) MXPA02003547A (zh)
NO (1) NO20021563L (zh)
NZ (1) NZ518637A (zh)
PE (1) PE20010631A1 (zh)
PT (1) PT1218380E (zh)
RU (1) RU2002110282A (zh)
SK (1) SK286450B6 (zh)
UY (1) UY26371A1 (zh)
WO (1) WO2001027110A2 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10043845A1 (de) * 2000-09-06 2002-03-14 Gruenenthal Gmbh Verfahren zur Messung der Aktivität der NO-Synthase
AU2002224927A1 (en) * 2000-12-13 2002-06-24 Basf Aktiengesellschaft Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
US7157460B2 (en) 2003-02-20 2007-01-02 Sugen Inc. Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
US7186832B2 (en) 2003-02-20 2007-03-06 Sugen Inc. Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
DE102004021716A1 (de) * 2004-04-30 2005-12-01 Grünenthal GmbH Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
DE102004044884A1 (de) * 2004-09-14 2006-05-24 Grünenthal GmbH Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
DE102005016547A1 (de) * 2005-04-08 2006-10-12 Grünenthal GmbH Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
CA2620223A1 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
WO2007138072A2 (en) * 2006-05-31 2007-12-06 Galapagos N.V. Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
WO2008134553A1 (en) * 2007-04-26 2008-11-06 Xenon Pharmaceuticals Inc. Methods of using bicyclic compounds in treating sodium channel-mediated diseases
AU2008277628B2 (en) 2007-07-18 2012-03-15 Novartis Ag Bicyclic heteroaryl compounds and their use as kinase inhibitors
WO2009065131A1 (en) * 2007-11-16 2009-05-22 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
US8129390B2 (en) * 2007-12-12 2012-03-06 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds and methods for using the same
CN102007133B (zh) * 2008-04-15 2013-06-12 卫材R&D管理有限公司 3-苯基吡唑并[5,1-b]噻唑化合物
ES2552549T3 (es) 2008-04-23 2015-11-30 Rigel Pharmaceuticals, Inc. Compuestos de carboxamida para el tratamiento de trastornos metabólicos
EP2334675B1 (en) 2008-09-16 2014-03-26 Csir Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
WO2010116302A1 (en) * 2009-04-07 2010-10-14 University Of The Witwatersrand, Johannesburg Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
AR078521A1 (es) * 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
KR101732212B1 (ko) * 2010-03-18 2017-05-02 재단법인 한국파스퇴르연구소 항감염성 화합물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489755A (en) 1966-08-03 1970-01-13 Pfizer & Co C Imidazo (1,2-b) pyridazines
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
NZ221996A (en) * 1986-10-07 1989-08-29 Yamanouchi Pharma Co Ltd Imidazo-pyridine derivatives and pharmaceutical compositions
TW274551B (zh) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
AU698867B2 (en) * 1995-04-21 1998-11-12 Shinnippon Pharmaceutical Inc. Fused imidazo 1,2-a pyridines

Also Published As

Publication number Publication date
UY26371A1 (es) 2000-10-31
NO20021563L (no) 2002-06-04
IL148998A (en) 2006-12-31
SK4612002A3 (en) 2002-09-10
PE20010631A1 (es) 2001-07-07
AU780823B2 (en) 2005-04-21
DK1218380T3 (da) 2004-03-15
WO2001027110A2 (de) 2001-04-19
JP2003517466A (ja) 2003-05-27
CA2386813C (en) 2008-09-02
EP1218380B1 (de) 2003-12-17
ES2213044T3 (es) 2004-08-16
US6849642B2 (en) 2005-02-01
CN1222525C (zh) 2005-10-12
CO5210870A1 (es) 2002-10-30
NZ518637A (en) 2004-12-24
US20020183327A1 (en) 2002-12-05
HUP0203739A3 (en) 2004-07-28
NO20021563D0 (no) 2002-04-03
CA2386813A1 (en) 2001-04-19
IL148998A0 (en) 2002-11-10
PT1218380E (pt) 2004-05-31
WO2001027110A3 (de) 2001-09-20
CN1402727A (zh) 2003-03-12
KR20020038804A (ko) 2002-05-23
SK286450B6 (sk) 2008-10-07
DE50004817D1 (de) 2004-01-29
EP1218380A2 (de) 2002-07-03
HK1047748A1 (en) 2003-03-07
ATE256684T1 (de) 2004-01-15
MXPA02003547A (es) 2002-09-18
PL364866A1 (en) 2004-12-27
CZ20021243A3 (cs) 2003-12-17
HUP0203739A2 (hu) 2003-02-28
BR0014826A (pt) 2002-08-27
AR025961A1 (es) 2002-12-26
RU2002110282A (ru) 2003-12-20
CZ300315B6 (cs) 2009-04-15
AU7519900A (en) 2001-04-23

Similar Documents

Publication Publication Date Title
ZA200203581B (en) Bicyclic imidazo-3-yl-amine derivatives.
GB2346097B (en) Retaining ring
PL355206A1 (en) Bicyclic imidazo-3-yl-amine derivatives
HK1043795A1 (en) Substituted bicyclic derivatives useful as anticancer agents.
HK1046128A1 (en) Fused ring compound
HK1047748A1 (en) Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
IL149010A0 (en) Bicyclic imidazo-5-yl-amine derivatives
AU4607301A (en) Ring oscillator
ZA200203580B (en) Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring.
SI1218380T1 (en) Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
AU1652901A (en) Safe ring
ZA200203582B (en) Bicyclic imidazo-5-yl-amine derivatives.
GB9912144D0 (en) The circle scribe
SI1218382T1 (en) Bicyclic imidazo-3-yl-amine derivatives
AU142337S (en) Ring
AU142478S (en) Ring
AUPQ392099A0 (en) The rim ring
DE29910388U1 (de) Verbundring
GB0011206D0 (en) The spider
TW385647U (en) Structure for ring
TW414273U (en) Ring locked insert
UA3605S (uk) Стопорне кільце
CA84117S (en) Ring
CA83397S (en) Ring
CA83398S (en) Ring

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090918